In one paragraphArticle in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Juliana Tonini MesquitaDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-1734-3400 Gabriel Cândido MouraDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Tainá CavalcanteDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Jenicer Kazumi Umada Yokoyama YasunakaDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Manoel Aparecido PeresDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Claudia Blanes AngeliDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Noemi Nosomi TaniwakiElectron Microscopy Nucleus, Institute Adolfo Lutz, São Paulo, São Paulo, Brazil.
Beatriz Simonsen StolfDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Giuseppe PalmisanoDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-1336-6151 Alejandro Miguel KatzinDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-4782-2162 Funding
Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/15549-1,2020/04923-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2021/01877-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2024/09997-2 and 2017/22452-1
6 · The paper itselfAbstract
Leishmaniasis is a parasitic disease caused by several species of the genus
Indexed as
Antiprotozoal AgentsLeishmaniaLeishmania mexicanaNaphthoquinonesNitrobenzoatesUbiquinoneAnimalsDrug Therapy, CombinationFemaleLeishmaniasisMembrane Potential, MitochondrialMiceMice, Inbred BALB CMitochondriaReactive Oxygen SpeciesAntiprotozoal AgentsbuparvaquoneNaphthoquinonesNitrobenzoatesReactive Oxygen SpeciesUbiquinonecombination therapyLeishmania (Leishmania) amazonensisleishmaniasistreatmentubiquinone therapeutic target
Identifiers
PMID41055407
PMCPMC12587604
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390